INCOME TAXES (Tables)
|
12 Months Ended |
Dec. 31, 2025 |
| Income Tax Disclosure [Abstract] |
|
| Schedule of Domestic and Foreign Components of Net Income (Loss) Before Income Taxes |
The domestic and foreign components of the Company’s Net Income (Loss) Before Income Taxes consists of the following for the periods presented (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | Years Ended December 31, | | | | 2025 | | 2024 | | 2023 | | United States | | $ | (35,534) | | | $ | (53,963) | | | $ | (106,384) | | | Foreign | | — | | | — | | | — | | | Net Loss Before Income Taxes | | $ | (35,534) | | | $ | (53,963) | | | $ | (106,384) | |
|
| Schedule of Components of Income Tax |
The components of the Company’s Income Tax Expense are as follows for the periods presented (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | Years Ended December 31, | | | | 2025 | | 2024 | | 2023 | | Current: | | | | | | | | Federal | | $ | — | | | $ | — | | | $ | — | | | State | | 137 | | | 28 | | | 15 | | | Foreign | | — | | | — | | | — | | | Total Current Income Tax Expense | | 137 | | | 28 | | | 15 | | | Deferred: | | | | | | | | Federal | | 47 | | | 47 | | | 47 | | | State | | (16) | | | 41 | | | 16 | | | Foreign | | — | | | — | | | — | | | Total Deferred Income Tax Expense | | 31 | | | 88 | | | 63 | | | Total Income Tax Expense | | $ | 168 | | | $ | 116 | | | $ | 78 | |
|
| Schedule of Effective Income Tax Reconciliation |
The following table presents required disclosures pursuant to ASU 2023-09 and reconciles the U.S. federal statutory income tax rate of 21% to the Company’s Net Loss Before Income Taxes for the year ended December 31, 2025 (dollar amounts in thousands): | | | | | | | | | | | | | | | | | | Year Ended December 31, 2025 | | | | Amount ($) | | Percent (%) | | U.S. federal statutory tax rate | | $ | (7,462) | | | 21 | % | State and local income taxes, net of federal income tax effect (1) | | 92 | | | — | % | | Tax credits | | | | | | Research and development tax credits | | 35 | | | — | % | | Changes in valuation allowances | | (2,545) | | | 7 | % | | Nontaxable or nondeductible items | | | | | | Share-based payment awards | | 866 | | | (2) | % | | Convertible Preferred Stock Warrants | | 8,842 | | | (25) | % | | Other | | 295 | | | (1) | % | | Changes in unrecognized tax benefits | | (9) | | | — | % | | Other U.S. federal adjustments | | | | | | Other | | 54 | | | — | % | | Effective income tax rate | | $ | 168 | | | — | % | (a) State taxes in Indiana, Massachusetts and Pennsylvania made up the majority (greater than 50%) of the tax effect in this category. |
The following table reconciles the U.S. federal statutory income tax rate of 21% to the Company’s Net Loss Before Income Taxes for the following periods prior to the year ended December 31, 2025: | | | | | | | | | | | | | | | | | | Years Ended December 31, | | | | 2024 | | 2023 | | U.S. federal tax at statutory rate | | 21 | % | | 21 | % | | State and local income taxes, net of federal income tax effect | | 8 | % | | 8 | % | | Share-based payment awards | | (1) | % | | (1) | % | | Convertible Preferred Stock Warrants | | (25) | % | | (12) | % | | Changes in valuation allowances | | 5 | % | | (18) | % | | Return-to-provision | | (3) | % | | (1) | % | | State tax rate changes | | (4) | % | | 2 | % | | Other | | (1) | % | | 1 | % | | Income Tax Expense | | — | % | | — | % |
|
| Schedule of Deferred Tax Assets and Liabilities |
Temporary items that give rise to significant portions of deferred tax assets and liabilities are as follows for the periods presented (in thousands): | | | | | | | | | | | | | | | | | | December 31, | | | | 2025 | | 2024 | | Net operating loss carry forwards | | $ | 97,359 | | | $ | 100,301 | | | Research and other credits | | 2,711 | | | 2,779 | | | Stock compensation | | 594 | | | 1,550 | | | Accrued liabilities | | 9,422 | | | 7,168 | | | Lease liabilities | | 2,269 | | | 3,507 | | | Property and equipment | | 4,992 | | | 3,998 | | | Section 174 R&D capitalization | | 5,499 | | | 9,480 | | | Total deferred tax assets | | 122,846 | | | 128,783 | | | Net servicing rights | | (1,184) | | | (509) | | | Intangible assets | | (5,924) | | | (2,826) | | | Right-of-use assets | | (1,661) | | | (2,559) | | | Total deferred tax liabilities | | (8,769) | | | (5,894) | | | Total net deferred tax asset | | 114,077 | | | 122,889 | | | Less: Valuation allowance | | (114,916) | | | (123,697) | | | Net deferred tax liability | | $ | (839) | | | $ | (808) | |
|
| Schedule of Income Taxes Paid, Net of Refunds Received |
ASU 2023-09 requires entities to provide additional disclosures about income taxes paid by jurisdiction. Applying these updated requirements on a prospective basis, cash payments made for income taxes, net of refunds, are as follows (in thousands): | | | | | | | | | | | | Year Ended December 31, 2025 | | California | | $ | 291 | | | Massachusetts | | 80 | | | Pennsylvania | | 47 | | | Other | | 91 | | | Total Income Taxes Paid, Net of Refunds Received | | $ | 509 | |
Supplemental cash flow information related to the Company’s operating leases is as follows (dollars in thousands): | | | | | | | | | | | | | | | | | | | | | | | | Years Ended December 31, | | | | 2025 | | 2024 | | 2023 | | Non-cash operating activity: | | | | | | | | ROU assets obtained or adjusted in exchange for new, amended and modified operating lease liabilities | | $ | — | | | $ | 35 | | | $ | (697) | |
|
| Schedule of Unrecognized Tax Benefits |
The following table summarizes the Company’s activity related to its unrecognized tax benefits (in thousands): | | | | | | | | | | Balance at December 31, 2022 | | $ | 1,291 | | | Change related to 2023 tax year position | | — | | | Balance at December 31, 2023 | | $ | 1,291 | | | Change related to 2024 tax year position | | — | | | Balance at December 31, 2024 | | $ | 1,291 | | | Change related to 2025 tax year position | | — | | | Change related to positions of prior tax years | | (112) | | | Balance at December 31, 2025 | | $ | 1,179 | |
|